GLP2-TZ 10mg
What is GLP2-TZ?
GLP2-TZ is a synthetic dual-agonist peptide studied for its activity at both GLP-1 and GIP receptors. Research literature highlights its role in studies of incretin receptor signaling models.
This 10mg research vial provides a starter quantity suitable for short-protocol in-vitro and pre-clinical investigation under controlled laboratory conditions.
Research Highlights
- Studied in receptor signaling models
- Dual GIP + GLP-1 receptor engagement
- Investigated in in-vitro assay models
- Researched for insulin sensitivity pathways
How It Works
GLP2-TZ engages two distinct incretin receptors (GIP and GLP-1) in research models, producing a complementary signaling effect studied across receptor signaling pathways.
Certificate of Analysis — GLP2-TZ 10mg
Tirzepatide · Tested strength: 10 mg/vial · Lot 082026glptz10G. Results apply to this reported lot and strength.
- Analyte
- Tirzepatide
- Batch / Lot
- 082026glptz10G
- Result
- 10.11 mg/vial
- Label Claim
- 10 mg/vial
- Purity
- >99%
- Method
- HPLC
- Date Tested
- 08/26/2026
Why Choose PWR Peptides?
- Research Use Only
Every product is intended strictly for laboratory and research applications.
- Secure Packaging
Discreet, temperature-conscious packaging protects each vial in transit.
- Fast Shipping
Most orders leave our US fulfillment center within 24 business hours.
- Responsive Support
Real humans reply to research and order questions, usually same-day.
- Batch Tracking
Batch identifiers are recorded for applicable products for full traceability.
Documentation is maintained for applicable product batches. Additional information may be available upon request when applicable. Contact support for inquiries.